Cyclopharm secures Technegas approval at NIH
Cyclopharm (ASX:CYC) announced the approval of its flagship technology, Technegas, for clinical use at the National Institutes of Health.
Cyclopharm (ASX:CYC) announced the approval of its flagship technology, Technegas, for clinical use at the National Institutes of Health.
The Northern Territory Government has launched a major international recruitment drive for gas exploration, unveiling a massive new acreage release in the Beetaloo Basin.
Energy giant Santos (ASX:STO) reported a full-year underlying net profit after tax of US$898 million, driven by sales volumes of 93.5 mmboe.
The Federal Court has ordered Mobil Oil Australia to pay $16 million in penalties for misleading consumers at nine service stations across north and central Queensland.
The Federal Court of Australia has dismissed a high-stakes lawsuit against oil and gas giant Santos (ASX:STO)
ADX Energy (ASX:ADX) has resumed testing operations at its Welchau-1 well in Upper Austria, following a favourable ruling by the State Administrative Court.
Origin Energy (ASX:ORG) reported a statutory profit of $557 million for H1 FY26, a sharp decline from the $1.02 billion recorded in the prior first half.
Omega Oil and Gas and Beach Energy expand their Queensland footprint, securing a 750km2 gas permit in the Taroom Trough to bolster domestic supply.
The New Zealand government has officially announced plans to begin importing liquefied natural gas by early 2028, marking a significant pivot in the nation’s energy policy.
Shell has launched a divestment process for its 16.67% stake in the North West Shelf joint venture.
Beach Energy (ASX:BPT) reported FY26 half-year results, with $982 million in revenue, offsetting a 7% production dip caused by Cooper Basin floods.
Cyclopharm (ASX:CYC) announced a capital raise totaling $16 million to accelerate the commercialisation of its flagship radiopharmaceutical product, Technegas, within the United States market.